| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $80.3B | $85.5B | $23.0B | $101.6B | $85.2B | $18.0B | $16.3B | $15.9B |
| Cost of Revenue | $75.2B | $79.8B | $86.4B | $94.0B | $79.3B | $59.9B | $60.5B | $60.2B |
| Gross Profit | $5.0B | $5.8B | $1.7B | $7.6B | $6.0B | $1.4B | $1.2B | $1.1B |
| R&D Expense | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| SG&A Expense | $3.6B | $3.7B | $3.5B | $3.4B | $3.0B | $2.7B | $2.5B | $2.2B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.1B | $1.8B | $0.6B | $4.3B | $2.7B | $0.7B | $0.5B | $0.3B |
| EPS (Basic) | $2.23 | $3.66 | $1.07 | $7.72 | $4.80 | $1.22 | $0.90 | $0.56 |
| EPS (Diluted) | $2.23 | $3.65 | $1.06 | $7.71 | $4.79 | $1.22 | $0.90 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $52.4B | $53.3B | $54.6B | $59.8B | $56.1B | $49.7B | $44.0B | $40.8B |
| Current Assets | $26.7B | $27.7B | $29.8B | $35.4B | $31.9B | $27.3B | $21.3B | $20.6B |
| Cash & Equivalents | $1.0B | $0.6B | $1.4B | $1.0B | $0.9B | $0.7B | $0.9B | $2.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $19.5B | $19.9B | $18.7B | $24.2B | $21.9B | $18.2B | $13.7B | $11.8B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.5B | $2.8B | $4.5B | $3.5B | $6.6B | $-2.4B | $-5.5B | $-4.8B |
| Investing Cash Flow | $-1.0B | $-2.7B | $-1.5B | $-1.4B | $-2.7B | $4.5B | $5.3B | $6.6B |
| Capital Expenditures | $1.2B | $1.6B | $1.5B | $1.3B | $1.2B | $0.8B | $0.8B | $0.8B |
| Financing Cash Flow | $-2.9B | $-1.5B | $-4.6B | $-2.5B | $-1.1B | $-0.4B | $-0.7B | $0.2B |